$2.18
+0.09 (+4.31%)
Open$2.08
Previous Close$2.09
Day High$2.24
Day Low$2.01
52W High$4.75
52W Low$1.27
Volume—
Avg Volume155.5K
Market Cap82.13M
P/E Ratio3.04
EPS$0.81
SectorPharmaceuticals
Analyst Ratings
Strong Buy
11 analysts
Price Target
+666.5% upside
Current
$2.18
$2.18
Target
$16.71
$16.71
$12.81
$16.71 avg
$20.08
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 197.50M | 187.70M | 22.38M |
| Net Income | 27.79M | 23.77M | 3.27M |
| Profit Margin | 14.1% | 13.4% | 14.6% |
| EBITDA | 51.93M | 46.89M | 5.70M |
| Free Cash Flow | — | — | 2.62M |
| Rev Growth | +5.2% | +5.2% | -5.1% |
| Debt/Equity | 9.02 | 9.02 | 0.18 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |